These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 12001122

  • 21. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
    Kyrtsonis MC, Vassilakopoulos TP, Siakantaris MP, Kokoris SI, Gribabis DA, Dimopoulou MN, Angelopoulou MK, Pangalis GA.
    Eur J Haematol; 2004 Apr; 72(4):252-8. PubMed ID: 15089762
    [Abstract] [Full Text] [Related]

  • 22. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myeloma.
    Takada S, Morita K, Hayashi K, Matsushima T, Sawamura M, Murakami H, Nojima Y.
    Eur J Haematol; 2005 Dec; 75(6):505-10. PubMed ID: 16313263
    [Abstract] [Full Text] [Related]

  • 23. High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment.
    Urbańska-Ryś H, Robak T.
    Mediators Inflamm; 2003 Aug; 12(4):229-35. PubMed ID: 14514474
    [Abstract] [Full Text] [Related]

  • 24. Prognostic factors in multiple myeloma.
    Kyle RA.
    Stem Cells; 1995 Aug; 13 Suppl 2():56-63. PubMed ID: 8520513
    [Abstract] [Full Text] [Related]

  • 25. Prognostic significance of the serum phosphorus level and its relationship with other prognostic factors in multiple myeloma.
    Umeda M, Okuda S, Izumi H, Nagase D, Fujimoto Y, Sugasawa Y, Arai C, Natori K, Katoh M, Kuraishi Y.
    Ann Hematol; 2006 Jul; 85(7):469-73. PubMed ID: 16528526
    [Abstract] [Full Text] [Related]

  • 26. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
    Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay JW, Matsuura Y, Yokoyama T.
    Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
    [Abstract] [Full Text] [Related]

  • 27. Determination of telomerase activity and telomere length.
    Wu KD, Moore MA.
    Methods Mol Med; 2005 Jul; 113():207-23. PubMed ID: 15968105
    [Abstract] [Full Text] [Related]

  • 28. [The significance of lactate dehydrogenase and beta 2-microglobulin levels for the assessment of the prognosis and choice of therapy in multiple myeloma].
    Iakovleva SV, Andreeva NE, Izgorodin AS.
    Ter Arkh; 1995 Jul; 67(7):35-9. PubMed ID: 7482303
    [Abstract] [Full Text] [Related]

  • 29. [Study of anti-myeloma activity of interleukin-2 activated bone marrow in vitro].
    Liu W, Chen SL, Liu JW, Li X, Xia CQ, Qi M.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):205-8. PubMed ID: 15949260
    [Abstract] [Full Text] [Related]

  • 30. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X, Le Friec G, Facon T, Amiot L, Fauchet R, Hennache B, Coiteux V, Yakoub-Agha I, Dubucquoi S, Avet-Loiseau H, Mathiot C, Bataille R, Mary JY, Intergroupe Francophone du Myélome.
    Clin Cancer Res; 2005 Oct 15; 11(20):7297-303. PubMed ID: 16243800
    [Abstract] [Full Text] [Related]

  • 31. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM.
    Anticancer Res; 2009 Apr 15; 29(4):1157-62. PubMed ID: 19414359
    [Abstract] [Full Text] [Related]

  • 32. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R, Rosenberg R, Stricker D, Werner M, Lassmann S, Ulm K, Nekarda H, Siewert JR.
    Cancer; 2002 Nov 15; 95(10):2103-11. PubMed ID: 12412163
    [Abstract] [Full Text] [Related]

  • 33. Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells.
    Handa H, Matsushima T, Nishimoto N, Inoue M, Saitoh T, Yokohama A, Tsukamoto N, Mitsui T, Nakahashi H, Toyama K, Karasawa M, Ogawara H, Nojima Y, Murakami H.
    Leuk Res; 2010 Feb 15; 34(2):177-83. PubMed ID: 19604579
    [Abstract] [Full Text] [Related]

  • 34. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
    Kawai J, Kodera Y, Fujiwara M, Kasai Y, Nagasaka T, Koike M, Hibi K, Ito K, Akiyama S, Nakao A.
    Hepatogastroenterology; 2005 Feb 15; 52(63):959-64. PubMed ID: 15966241
    [Abstract] [Full Text] [Related]

  • 35. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
    Ribas C, Colleoni GW, Silva MR, Carregoza MJ, Bordin JO.
    Eur J Haematol; 2004 Nov 15; 73(5):311-7. PubMed ID: 15458509
    [Abstract] [Full Text] [Related]

  • 36. Telomerase activity in stage II colorectal carcinoma.
    Kawanishi-Tabata R, Lopez F, Fratantonio S, Kim N, Goldblum J, Tubbs R, Elson P, Lavery I, Bukowski RM, Ganapathi R, Ganapathi MK.
    Cancer; 2002 Nov 01; 95(9):1834-9. PubMed ID: 12404275
    [Abstract] [Full Text] [Related]

  • 37. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO, Sahin B, Paydas S, Cetiner S.
    Saudi Med J; 2004 Nov 01; 25(11):1587-92. PubMed ID: 15573184
    [Abstract] [Full Text] [Related]

  • 38. Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.
    Fonseca R, Harrington D, Oken MM, Dewald GW, Bailey RJ, Van Wier SA, Henderson KJ, Blood EA, Rajkumar SV, Kay NE, Van Ness B, Greipp PR.
    Cancer Res; 2002 Feb 01; 62(3):715-20. PubMed ID: 11830525
    [Abstract] [Full Text] [Related]

  • 39. [Detection of multiple myeloma cells using multicolor immunofluorescence and flow cytometry].
    Tousková M, Maisnar V, Krejsek J, Kopecký O.
    Vnitr Lek; 1999 Dec 01; 45(12):708-12. PubMed ID: 10951845
    [Abstract] [Full Text] [Related]

  • 40. Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia.
    Verstovsek S, Giles FJ, O'Brien S, Faderl S, Kantarjian HM, Keating MJ, Albitar M.
    Leuk Res; 2004 Jul 01; 28(7):707-11. PubMed ID: 15158092
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.